VCM
SCMP

Virtue Capital Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Virtue Capital Management’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-7
Closed – – 692
2017
Q4 		$0 Buy
+7
New +$86 ﹤0.01% 535

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Virtue Capital Management's SCMP Position: Q1 2018 in Review

Virtue Capital Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 7 shares.

Virtue Capital Management first reported a position in SCMP in Q4 2017 and held it in 1 quarter. The position peaked at $0 in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Virtue Capital Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Virtue Capital Management sold 7 Sucampo Pharmaceuticals, Inc. shares in Q1 2018.
  • Virtue Capital Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2017 and held it in 1 quarter.
  • Virtue Capital Management's Sucampo Pharmaceuticals, Inc. position peaked at $0 in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Virtue Capital Management's 13F filing for Q1 2018, filed 15 May 2018.